Physician profile
William Tosches
NPI 1841390952
$2,332.13
in general payments reported to CMS, 2019-2025
26 companies · $20.54 in 2025
The $20.54 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,993 · 2021: $160 · 2022: $62.15 · 2023: $81.98 · 2024: $14.63 · 2025: $20.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $346.18 | 2019 | |
| Biogen, INC. | $254.86 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $250.16 | 2019 | |
| Ucb, INC. | $233.41 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $162.30 | 2019 | |
| Eisai INC. | $145.71 | 2019-2023 | |
| Neurocrine Biosciences, INC. | $123.39 | 2019 | |
| Sk Life Science, INC. | $104.43 | 2021-2025 | |
| Genzyme Corporation | $78.45 | 2019 | |
| Supernus Pharmaceuticals, INC. | $78.11 | 2019 | |
| Acadia Pharmaceuticals INC | $68.72 | 2019 | |
| Amneal Pharmaceuticals LLC | $63.00 | 2019-2022 | |
| Acorda Therapeutics, INC | $61.50 | 2019 | |
| Mdd US Operations, LLC | $60.72 | 2019-2021 | |
| Grifols USA, LLC | $48.73 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $40.94 | 2019 | |
| Avanir Pharmaceuticals, INC. | $38.52 | 2019 | |
| Pfizer INC. | $35.14 | 2019 | |
| Arbor Pharmaceuticals, INC. | $25.51 | 2019 | |
| Celgene Corporation | $19.46 | 2019 | |
| Abbvie INC. | $18.19 | 2021 | |
| Lilly USA, LLC | $15.70 | 2019 | |
| Shire North American Group INC | $15.55 | 2019 | |
| Assertio Therapeutics, INC. | $15.09 | 2019 | |
| Emd Serono, INC. | $14.28 | 2019 | |
| Lundbeck LLC | $14.08 | 2023 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Tosches listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.